Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disease caused by a loss of the dystrophin protein. Control of dystrophin mRNA splicing to convert severe DMD to a milder phenotype is attracting much attention. Here we report a dystrophinopathy patient who has a point mutation in exon 31...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113229/ |